Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000206942 | SCV002933118 | uncertain significance | Dilated cardiomyopathy 1KK | 2022-06-10 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 217 of the MYPN protein (p.Ala217Glu). This variant is present in population databases (rs199476403, gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of MYPN-related conditions (PMID: 22286171). ClinVar contains an entry for this variant (Variation ID: 31813). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Leiden Muscular Dystrophy |
RCV000024506 | SCV000045810 | not provided | not provided | 2012-04-27 | no assertion provided | curation | |
Clin |
RCV000206942 | SCV000244048 | uncertain significance | Dilated cardiomyopathy 1KK | 2013-06-27 | no assertion criteria provided | literature only |